NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Matrix Metalloproteinase


Return to Library

Free Matrix Metalloproteinase Articles


Report summarizes breast cancer study findings from S.M. Eck and co-researchers



2009 AUG 3 - (NewsRx.com) -- "Matrix metalloproteinase-1 (MMP-1) is critical for mediating breast cancer metastasis to bone. We investigated the role of MMP-1 in breast cancer invasion of soft tissues and bone using human MDA MB-231 breast cancer cells stably transfected with shRNAs against MMP-1 and a novel murine model of bone invasion," researchers in Lebanon report.

"MMP-1 produced by breast cancer cells with control shRNA facilitated invasion of tumors into soft tissue in vivo, which correlated with enhanced blood vessel formation at the invasive edge, compared to tumors with silenced MMP-1 expression. Tumors expressing MMP-1 were also associated with osteolysis in vivo, whereas tumors with inhibited MMP-1 levels were not. Additionally, tumor-secreted MMP-1 activated bone-resorbing osteoclasts in vitro. Together, these data suggest a mechanism for MMP-1 in the activation of osteoclasts in vivo," wrote S.M. Eck and colleagues.

The researchers concluded: "Breast cancer-derived MMP-1 mediates invasion through soft tissues and bone via mechanisms involving matrix degradation, angiogenesis, and osteoclast activation.."

Eck and colleagues published their study in Breast Cancer Research and Treatment (Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model. Breast Cancer Research and Treatment, 2009;116(1):79-90).

For additional information, contact C.E. Brinckerhoff, Norris Cotton Cancer Center, Dept. of Medical, 1 Med Center Dr., Rubin Bldg, HB 7936, Lebanon, NH 03756, USA.

Publisher contact information for the journal Breast Cancer Research and Treatment is: Springer, 233 Spring St., New York, NY 10013, USA.

Keywords: Lebanon, Angiogenesis, Blood Vessel Formation, Bone, Breast Cancer, Breast Carcinoma, Cancer Research, Enzyme Research, Matrix Metalloproteinase, Metalloproteinases, Oncology, Osteolysis, Proteins, Proteomics, Tumor Vascularization, Women's Health.

This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2009, Clinical Oncology Week via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login